Correction
==========

The authors would like to apologize for failing to attribute text in their manuscript \[[@B1]\]. The following sentences were not referenced correctly as a direct quotation:

\"Ras protein is activated transiently as a response to extracellular signals, such as growth factors, cytokines, and hormones that stimulate cell surface receptors. It can switch between an inactive state, in which the proteins are bound to guanosine-diphosphates, and an active state, in which conversion to guanosine- triphosphate (GTP) occurs. Mutant activated forms of Ras proteins have an impaired intrinsic GTPase activity, which renders the protein resistant to inactivation by regulatory GTPase-activating proteins\" \[[@B2]\].

In addition, the following errors were made in the Abstract, paragraph 2 of the Results and Table two of the original publication \[[@B1]\]:

1\. The methods described in the Abstract as \"polymerase chain reaction-single strand conformational polymorphism\" should be \"polymerase chain reaction and Sanger sequencing\".

2.The sentence in the Results (paragraph 2) \"leading to substitution of a glutamine by leucine acid (Gln849Leu)\" should be replaced by \"leading to substitution of a Lysine by Arginine (Lys728Arg).\" The sentence \"leading to transitions of Lys728Arg and Ala871Thr.\" should be \"leading to transitions of Gln849Leu and Ala871Thr.\"

3.In the EGFR column of Table two of the original publication, Gln849Leu in the first row should be replaced by Lys728Arg. In the second row of the same column, Lys728Arg should be replaced by Gln849Leu. The corrections are shown in Table [1](#T1){ref-type="table"}.

###### 

Corrections to Table two \"Epidermal growth factor receptor and K-ras mutations\"

          Site       Wild type   Type of point mutation   Number of mutations (%)   Amino acid   Heterozygous/homozygous
  ------- ---------- ----------- ------------------------ ------------------------- ------------ -------------------------
  EGFRa   Exon 18    AAG         2183A\>G                 1 (33.3)                  Lys728Arg    Heterozygous
          Exon 21    CAG         2546A\>T                 1 (33.3)                  Gln849Leu    Heterozygous
          Exon 21    GCA         2611G\>A                 1 (33.3)                  Ala871Thr    Heterozygous
                                                                                                 
  K-ras   Codon 12   GGT         35G\>A                   16 (47.1)                 Gly12Asp     Heterozygous
          Codon 12   GGT         34G\>T                   6 (17.6)                  Gly12Cys     Heterozygous
          Codon 12   GGT         34G\>A                   3 (8.8)                   Gly12Ser     Heterozygous
          Codon 12   GGT         34G\>A                   1 (2.9)                   Gly12Ser     Homozygous
          Codon 12   GGT         34G\>T                   1 (2.9)                   Gly12Cys     Homozygous
          Codon 12   GGT         35G\>C                   1 (2.9)                   Gly12Ala     Heterozygous
          Codon 12   GGT         35G\>A                   1 (2.9)                   Gly12Asp     Homozygous
          Codon 12   GGT         35G\>T                   1 (2.9)                   Gly12Val     Heterozygous
          Codon 13   GGC         38G\>A                   1 (2.9)                   Gly13Asp     Heterozygous
          Codon 45   GTA         133G\>A                  1 (2.9)                   Val45Ile     Homozygous
          Codon 69   GAC         205G\>A                  1 (2.9)                   Asp69Asn     Homozygous
          Codon 80   TGT         239G\>A                  1 (2.9)                   Cys80Tyr     Heterozygous

Corrections to Table 2 \"Epidermal growth factor receptor and K-ras mutations\" in the original publication \[[@B1]\] are shown in Table 1 of this Correction as follows: In the EGFR column of Table 2, Gln849Leu in the first row should be replaced by Lys728Arg. In the second row of the EGFR column, Lys728Arg should be replaced by Gln849Leu, as shown in Table 1 of this Correction.
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